SciFi Futures
← Capabilities
Biotech & Medicine/Foundational science

Prediction of pathogen transmissibility and virulence from sequence

Predicting how a changed genome will behave in a human population - how contagious, how lethal, how immune-evasive - without having to test it.

State of the art

A RAND Delphi study (2025) concluded that AI-enabled design can plausibly assist optimization of existing pathogens but that prediction of population-level transmissibility remains out of reach; AI protein design can produce functional variants whose phenotype is still only knowable by experiment.

What’s blocking it
  • Transmissibility is an emergent property of host behavior, immunity and ecology, not of sequence alone
  • Animal and organoid models correlate poorly with human epidemic potential
  • The experiments that would validate such predictions are the ones that must not be run

Who’s working on it

  • Debora MarksResearcher
    Harvard Medical School

    Built EVEscape for antibody-escape forecasting (Nature, 2023) and the EVEREST viral variant-effect benchmark (2026), which deliberately excludes virulence endpoints

  • Trevor BedfordResearcher
    Nextstrain, previously Fred Hutchinson Cancer Center and HHMI

    His 2024 to 2026 frequency-dynamics framework separates intrinsic transmissibility from immune escape using sequence data alone, the closest thing to a population-level predictor

  • Open real-time phylogenetics platform, with its automation paper published September 2026, supplying the surveillance data any predictive model is judged against

  • RAND Global and Emerging RisksProgram

    Ran the 2025 Delphi elicitation finding no method maps sequence to human transmissibility, and a 2026 assessment of whether LLM agents can drive biological design tools

  • CEPI ↗Program

    Funded the EVEREST benchmark and supplied the biosecurity review that kept harm-enhancing phenotypes out of the released datasets in 2026

  • Latch BioStartup

    Released the BioSecBench benchmarks in 2026, measuring whether AI agents can infer transmissibility, immune escape and virulence from experimental data

What to invest in

KindInvestmentScale
researchPredictive modelling benchmarked only on historical natural variants and attenuated systems, with structured hazard review$$ $10M – $100M
policyGovernance of dual-use predictive tools, including access controls and audited evaluation environments$ < $10M

Sci-fi concepts in reach

Engineered pandemic organismgatingdirect

Sources